This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Investment Opportunities

Filter
  • Stage
  • Sector

Capital at Risk. Please read our risk warning and disclaimer

There was a problem loading the results. Try again?
overfunding
  • EIS
3 days left

Cotswolds Distillery

The Cotswolds Distillery is one of the most highly rated artisanal distillers of gin and whisky in the world. Sold in Harrods, Majestic Wine, local Waitrose and other top UK outlets, and in 28 countries, average sales growth has exceeded 100% pa. Now funding to build brand awareness and long term growth.

£2,000,000 Target
121%
Raised
£2,427,740
Equity
7.46%
Investors
993
overfunding
  • EIS
26 days left

1854 Media

1854 Media is an award-winning digital media business with a fast-growing global audience of millions. Following five consecutive record-breaking quarters, 1854 is ready to accelerate growth of its core business and scale its rapidly growing content agency, increasing its share of this $200bn market.

£400,000 Target
133%
Raised
£535,360
Equity
10.20%
Investors
226
overfunding
  • EIS
3 days left

East London Liquor Company

The first gin, vodka and whisky distillery in east London in over 100 years, East London Liquor Company produces and imports a range of quality spirits. Currently listed in over 1000 accounts in the UK and exporting to 20 markets, ELLC is seeking investment to drive growth in the UK and abroad.

£750,000 Target
184%
Raised
£1,384,780
Equity
8.45%
Investors
920
overfunding
  • EIS
5 days left

Cell Guidance Systems

Cell Guidance Systems is developing a patented technology to unlock the medical potential of growth factor proteins. PODS enables proteins to treat diseases, such as Parkinson's disease and osteoarthritis, by improving their delivery to the disease site. The technology addresses multi-$bn markets.

£500,000 Target
140%
Raised
£702,560
Equity
7.06%
Investors
710
overfunding
26 days left

Notes Coffee

Notes is a growing coffee shop and wine bar concept, which has established itself as one of the market leaders in London's quality coffee market. Starting from a coffee cart in 2010, the company has grown to 9 prime central locations, with its own roastery and annual revenue of £5m.

£600,000 Target
110%
Raised
£665,250
Equity
6.24%
Investors
341
20 days left

ENXRAY

Backed by angels and grant funding, EnXray is an early stage company with a novel and proprietary Low Energy X-ray (LEXR) to sterilise high-value therapeutics, such as cancer vaccines and stem cell implants for engineering organs. The company is preparing to launch its first product in Q4 2018.

£400,000 Target
67%
Raised
£270,280
Equity
7.51%
Investors
149
  • EIS
26 days left

The Park Brewery

Already selling to over 100 outlets, The Park Brewery is a London microbrewery producing innovative, thought-provoking and tasty beer. The company is raising funds to expand production fivefold, move to new premises, build a tap room, grow a passionate team and develop their range of beers.

£175,000 Target
72%
Raised
£126,610
Equity
10.45%
Investors
142
  • EIS
24 days left

ISO Spaces

ISO Spaces is an award-winning, innovation-focused company that designs and off-site manufactures high-end, portable spaces from shipping containers. They've produced pop-up units for blue-chip clients, including Jeep and Fever-Tree, and have now expanded into the modular housing market.

£500,000 Target
15%
Raised
£78,980
Equity
2.44%
Investors
112
  • EIS
  • SEIS
10 days left

Celo

Celo is an app-based insurance provider designed to provide cheaper quotes, faster claims, and a pleasant user experience. We plan to offer insurance cover for motor vehicles, travel, health, and more. Like Monzo and Starling who are disrupting banking, Celo plans to disrupt the insurance industry.

£100,000 Target
78%
Raised
£78,850
Equity
25.00%
Investors
213
There was a problem loading the results. Try again?

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated.

Please click here to read the full risk warning. This page is approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Crowdcube takes no responsibility for this information or for any recommendations or opinions made by the companies.

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.